KalVista Pharmaceuticals (KALV) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2025)
KalVista Pharmaceuticals (KALV) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -1.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -1.57% |
| Apr 30, 2025 | -10.73% |
| Oct 31, 2024 | -18.51% |
| Jul 31, 2024 | -25.35% |
| Apr 30, 2024 | -24.46% |
| Jan 31, 2024 | -20.22% |
| Oct 31, 2023 | -18.24% |
| Jul 31, 2023 | -7.16% |
| Apr 30, 2023 | 35.35% |
| Jan 31, 2023 | 37.11% |
| Oct 31, 2022 | 40.37% |
| Jul 31, 2022 | 55.86% |
| Apr 30, 2022 | 21.61% |
| Jan 31, 2022 | 18.58% |
| Oct 31, 2021 | 15.40% |
| Jul 31, 2021 | -3.71% |
| Apr 30, 2021 | -12.33% |
| Jan 31, 2021 | -17.35% |
| Oct 31, 2020 | -20.13% |
| Jul 31, 2020 | -10.47% |